Target intelligence / Profile preview

Connector enhancer of kinase suppressor of Ras 2 (CNKSR2)

Target
CNKSR2
Molecular classification
Other (scaffold protein, multidomain adaptor)
01

Overview

Connector enhancer of kinase suppressor of Ras 2 (CNKSR2, also known as CNK2 or MAGUIN) is a multidomain scaffold protein encoded by the *CNKSR2* gene on the X chromosome[1][2][3][5]. It contains domains such as SAM, PDZ, PH, and CRIC, enabling it to interact with multiple proteins in signaling complexes. CNKSR2 regulates the mitogen-activated protein kinase (MAPK) pathway downstream of Ras and coordinates the assembly of synaptic proteins at postsynaptic sites[1][2][3][5]. It plays a critical role in neuronal development, promoting dendrite and dendritic spine formation, and is implicated in various neurodevelopmental disorders including intellectual disability, epilepsy, and autism spectrum conditions[2][3][5]. Defects or mutations in CNKSR2 result in X-linked intellectual disability with associated neurological symptoms. No direct drugs are listed that target CNKSR2, and it is not primarily considered a therapeutic target but is a significant disease gene in neurodevelopmental genetics[2][3][5].

Other names
CNK2KSR2MAGUINCNK homolog protein 2KIAA0902MRXSHGmembrane-associated guanylate kinase-interacting protein
02

Biological functions

Signal transductionRegulation of MAPK/ERK pathwaySynaptic organizationDendritic developmentNeuronal differentiation and maturationApoptosis inhibition (context-dependent)
03

Disease associations

Neurodevelopmental disorder (X-linked intellectual disability, Houge-type)EpilepsyAutism spectrum disorderAttention deficit hyperactivity disorderSpeech and language delay
04

Safety considerations

Loss-of-function mutations result in neurodevelopmental disorders, including epilepsy, intellectual disability, hyperactivity, and language delay.

Beyond the preview

Go deeper on Connector enhancer of kinase suppressor of Ras 2 (CNKSR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connector enhancer of kinase suppressor of Ras 2 (CNKSR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call